[1]
L. C. Martins et al., “USE OF CANNABINOIDS IN THE TREATMENT OF PSYCHIATRIC DISORDERS: EVIDENCE AND CHALLENGES”, REASE, vol. 11, no. 3, pp. 728–738, Mar. 2025, doi: 10.51891/rease.v11i3.18390.